(Zero Hedge)—For years, Washington assumed that China’s outbound investment flowed mainly into developing economies hungry for infrastructure money. But as scrutiny tightens across the West, it’s becoming clear that Beijing’s financial reach extended far deeper into wealthy nations – and far earlier – than most policymakers realized.
One early warning came in 2016, when Jeff Stein, a veteran journalist covering U.S. intelligence agencies, received an unusual tip: Wright USA, a small insurer that specialized in providing liability coverage for FBI and CIA personnel, had quietly been acquired the year before by Fosun Group, a Chinese conglomerate with reported ties to Beijing’s leadership. “Someone with direct knowledge called me up and said, ‘Do you know that the insurance company that insures intelligence personnel is owned by the Chinese?’” Stein recalls. “I was astonished.”
The concern was immediate and obvious. Wright USA held personal information on some of the most sensitive employees in the federal government. The question in Washington became not what the Chinese buyer intended, but who might ultimately gain access to the data. Newly released records reviewed by the BBC indicate that Chinese state banks helped finance the acquisition, routing a $1.2 billion loan through the Cayman Islands to enable Fosun’s purchase.
Though the deal violated no U.S. laws, it triggered alarm. Stein’s story in Newsweek soon prompted a rare inquiry by the Committee on Foreign Investment in the United States (CFIUS), the Treasury-led interagency panel responsible for policing foreign ownership risks. Within months, Wright USA was sold back to American owners. Neither Fosun nor Starr Wright USA, its new parent, responded to requests for comment.
High-level intelligence officials say the episode was among the cases that pushed the first Trump administration in 2018 to significantly tighten U.S. investment screening – part of a broader shift as the U.S. began rethinking a two-decade-old presumption that Chinese capital posed few national-security risks.
New research now suggests the Wright USA case was not an anomaly, but one instance in a vast global pattern. AidData, a research lab at William & Mary, has completed what it calls the first comprehensive tally of China’s state-backed investments abroad. Its findings, shared in advance with the BBC, show that Beijing has spent $2.1 trillion overseas since 2000 – roughly half in developing countries and half in advanced economies such as the United States, the United Kingdom, Germany, and Australia.
“For many years, we assumed China’s money flows were going to developing countries,” said Brad Parks, AidData’s executive director. “It came as a great surprise when we realized hundreds of billions were flowing into wealthy markets, happening right underneath our noses.”
China’s ability to project financial power abroad is tied to the enormous scale of its domestic banking system – now larger than those of the U.S., Europe, and Japan combined. Beijing exercises direct control over interest rates and credit allocation, giving it tools few governments possess. “This is only possible with very strict capital controls, which no other country could sustain,” said Victor Shih, director of the 21st Century China Center at the University of California, San Diego.
Many of the investments mapped by AidData appear commercial in nature. But others align with China’s long-running industrial strategy, including the now-muted – but still operative – “Made in China 2025” program, which aims to dominate sectors such as robotics, electric vehicles, and semiconductors.
Western governments have since moved aggressively to strengthen screening mechanisms over inbound capital. In the U.K., the U.S., and the Netherlands, regulators have derailed or unwound deals over fears that Chinese buyers could access strategically sensitive technologies. The Dutch government recently intervened in the operations of Nexperia, a Chinese-owned semiconductor firm, citing concerns that chip technologies could be transferred to its parent company. The move effectively split Nexperia’s Dutch operations from its China-based manufacturing arm – an extraordinary step in a country long known for economic openness.
But policymakers also warn against overcorrection. “There’s a danger of making it seem as if China is this monolith,” said Xiaoxue Martin, a research fellow at the Clingendael Institute in The Hague. “Most companies, especially private ones, just want to make money. They don’t want the negative reception they’re getting in Europe.”
Beijing rejects claims that its overseas investments are tools of statecraft. “Chinese companies… contribute actively to local economic growth, social development and job creation,” the Chinese embassy in London told the BBC, adding that they strictly follow local laws.
Still, the scale of the financing behind many transactions raises questions about where commercial intent ends and strategic interest begins. What Western officials now see, Parks argues, is a coordinated push. “At first, they thought these were individual initiatives from Chinese companies,” he said. “What they’ve learned is that Beijing’s party-state is behind the scenes writing the checks.”
(h/t Capital.news)
For Emergency Preparedness, Don’t Forget the Meds
Being prepared is more than just a good idea—it’s essential. We stock up on non-perishable food, bottled water, flashlights, and first-aid supplies, but one critical aspect often gets overlooked: access to vital medications. What happens if pharmacies close, prescriptions can’t be filled, or you’re cut off from medical care during an emergency?
That’s where Jase Medical steps in, offering a reliable solution to ensure you and your family have the medications you need when it matters most.
Jase Medical specializes in emergency preparedness kits designed to provide peace of mind through physician-reviewed, prescription medications delivered right to your door. Their flagship product, the Jase Case, is a comprehensive emergency antibiotic and medication kit priced at $289.95.
This kit includes 10 essential medications—five life-saving antibiotics and five symptom relief meds—that can treat over 50 common infections and illnesses, from urinary tract infections and pneumonia to skin infections and traveler’s diarrhea. With 28 add-on options available, you can customize the kit to fit your specific needs, including a KidCase for children ages 2-11.
The process is straightforward and hassle-free. Simply visit Patriot.tv/meds, complete an online evaluation, and have your order reviewed by a board-certified physician. Once approved, the medications are shipped discreetly from a licensed pharmacy to your U.S. address (with plans for Canada shipping coming soon). Each kit comes with detailed Med Cards outlining symptoms, dosing, and usage, making it easy to administer even in high-stress situations. These medications are shelf-stable and designed for long-term storage, empowering you to handle medical emergencies without relying on external help.
For those on the move, Jase Medical also offers the Jase Go kit for $129.95, a compact travel med kit covering over 30 common conditions encountered during adventures or trips. And for ongoing needs, Jase Daily provides an extended supply of your prescribed chronic medications to safeguard against disruptions in supply chains or extreme weather events.
Don’t just take our word for it—thousands of satisfied customers have given Jase Medical a 4.9-star rating, praising its role in true preparedness. As radio host Glenn Beck warns, “The supply lines for antibiotics already are stressed to the max. Please have some antibiotics on hand… You can do it through Jase.”
Whether you’re prepping for a hurricane, a power outage, or simply the uncertainties of daily life, Jase Medical ensures you’re not caught off guard. Head to patriot.tv/meds today to customize and order your emergency kit—because when it comes to your health and safety, it’s better to be prepared than sorry.